Danaher Corporation reported $25.1B of revenue over the trailing twelve months, +4.6% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $25.1B (to Q2 2026). Net income: $4.00B, trailing twelve months to Q2 2026. Free cash flow: $5.47B, trailing twelve months to Q2 2026. Operating margin: 20%, trailing twelve months to Q2 2026.

DHRDanaher Corporation

Healthcare

$219.80+13% 1Y

$219.80

$161.9152 weeks$241.54

DHR as reported

Danaher Corporation reported $25.1B of revenue over the trailing twelve months, +4.6% on the year before. 11 reported series are charted on this page, each one as filed.

$25.1B

Revenue, trailing twelve months · to Q2 2026 · +4.6% against the twelve months before

Net income: $4.00B
Net income · +17% year on year · trailing twelve months to Q2 2026
Free cash flow: $5.47B
Free cash flow · +12% year on year · trailing twelve months to Q2 2026
Operating margin: 20%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for DHR, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$25.1B	+4.6%	Q2 2026
Net income	$4.00B	+17%	Q2 2026
EPS	$5.63	+20%	Q2 2026
Gross margin	59%	n/a	Q2 2026
Operating margin	20%	n/a	Q2 2026
Net margin	16%	n/a	Q2 2026
ROE	7.1%	n/a	Q2 2026
ROA	4.4%	n/a	Q2 2026
ROIC	5.6%	n/a	Q2 2026
Free cash flow	$5.47B	+12%	Q2 2026
P/E	39.0	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.